Eloxx Pharmaceuticals, Inc. (ELOX)
15.51
-0.20
(-1.27%)
USD |
OTCM |
Oct 02, 16:00
15.32
-0.19
(-1.23%)
After-Hours: 20:00
Eloxx Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2015 | -10.28K% |
| September 30, 2015 | -481.9% |
| June 30, 2015 | -2.42K% |
| March 31, 2015 | -3.27K% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | -1.78K% |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | -763.8% |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | -1.22K% |
| Date | Value |
|---|---|
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | -1.78K% |
| December 31, 2008 | |
| September 30, 2008 | -590.7% |
| June 30, 2008 | |
| March 31, 2008 | -2.58K% |
| December 31, 2007 | -20.88K% |
| September 30, 2007 | -102.9% |
| June 30, 2007 | -2.29K% |
| March 31, 2007 | -12.92K% |
| December 31, 2006 | -626.7% |
| September 30, 2006 | -739.5% |
| June 30, 2006 | -12.68K% |
| March 31, 2006 | -2.03K% |
| December 31, 2005 | -7.31K% |
| September 30, 2005 | -7.18K% |
| June 30, 2005 | -3.77K% |
| March 31, 2005 | -5.44K% |
| December 31, 2004 | -553.7% |
| September 30, 2004 | -4.43K% |
| June 30, 2004 | -3.70K% |
| March 31, 2004 | -9.93K% |
| December 31, 2003 | |
| September 30, 2003 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -- |
| CorMedix, Inc. | 25.50% |
| BioStem Technologies, Inc. | -113.6% |
| Wave Life Sciences, Inc. | -3.05K% |
| Axsome Therapeutics, Inc. | -23.50% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -28.62K% |
| Return on Assets | -65.48% |
| Return on Invested Capital | -455.8% |
| Return on Net Operating Assets | -1.13K% |